Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook

Group 1 - Colgate-Palmolive Company (NYSE:CL) is recognized as one of the 14 Best Dividend Aristocrats to invest in heading into 2026 [1] - BofA raised its price target on Colgate-Palmolive to $90 from $88, maintaining a Buy rating, while expressing concerns about consumption growth in the consumer staples sector for 2026 [2] - Jefferies adopted a more cautious stance on Colgate-Palmolive, citing softer expectations for oral care and slowing demand in premium pet products as key concerns [3] Group 2 - In its Q3 2025 earnings report, Colgate-Palmolive highlighted a challenging operating environment due to consumer uncertainty, tariffs, geopolitics, and high cost inflation impacting sales and profit growth [4] - The company emphasized its 2030 Strategy, focusing on a portfolio of healthy brands in growing categories, strong market positions, and a broad global footprint, with nearly 50% of revenue exposure from faster-growing emerging markets [4] - Colgate-Palmolive is a global consumer products company specializing in everyday household staples, particularly in oral care, personal care, and home care products [5]